Kewaunee Scientific Corporation
KEQU
$36.68
$0.110.30%
NASDAQ
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.88% | -0.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.88% | -0.99% | |||
| Cost of Revenue | -1.37% | 0.95% | |||
| Gross Profit | 14.56% | -5.96% | |||
| SG&A Expenses | 0.41% | 2.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.95% | 1.25% | |||
| Operating Income | 102.01% | -37.13% | |||
| Income Before Tax | 196.51% | -53.55% | |||
| Income Tax Expenses | 101.52% | -42.30% | |||
| Earnings from Continuing Operations | 243.12% | -57.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 20.83% | -312.90% | |||
| Net Income | 389.60% | -71.70% | |||
| EBIT | 102.01% | -37.13% | |||
| EBITDA | 62.02% | -26.52% | |||
| EPS Basic | 389.48% | -71.69% | |||
| Normalized Basic EPS | 331.46% | -70.05% | |||
| EPS Diluted | 390.57% | -71.95% | |||
| Normalized Diluted EPS | 329.81% | -69.99% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.40% | -0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||